(Q74524899)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11561683%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

title

Phase II studies of bryostatin-1 in patients with advanced sarcoma and advanced head and neck cancer (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11561683%20AND%20SRC:MED&resulttype=core&format=json

advanced head and neck cancer

11 November 2019

main subject

1 reference

1 reference

head and neck carcinoma

1 reference

8

E E Vokes

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11561683%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

author name string

B Brockstein

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11561683%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

B Samuels

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11561683%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

R Humerickhouse

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11561683%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

R Arietta

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11561683%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

P Fishkin

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11561683%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

J Wade

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11561683%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

J Sosman

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11561683%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

publication date

1 January 2001

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11561683%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

number of pages

6

1 reference

Investigational New Drugs

inferred from page(s)

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11561683%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

volume

19

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11561683%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11561683%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

page(s)

249-254

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11561683%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1023/a:1010628903248

11 November 2019

exact match

0 references

cites work

Selective translocation of beta II-protein kinase C to the nucleus of human promyelocytic (HL60) leukemia cells

1 reference

12 December 2020

Phase I study of bryostatin 1: assessment of interleukin 6 and tumor necrosis factor alpha induction in vivo. The Cancer Research Campaign Phase I Committee

1 reference

12 December 2020

A phase II study of bryostatin 1 in metastatic malignant melanoma

1 reference

12 December 2020

Phase I study of bryostatin 1 in patients with relapsed non-Hodgkin's lymphoma and chronic lymphocytic leukemia

1 reference

12 December 2020

Bryostatin 1 enhances paclitaxel-induced mitochondrial dysfunction and apoptosis in human leukemia cells (U937) ectopically expressing Bcl-xL

1 reference

12 December 2020

Chemotherapy of squamous cell carcinoma of head and neck: the future is now.

1 reference

12 December 2020

A Phase I trial of bryostatin-1 in children with refractory solid tumors: a Pediatric Oncology Group study.

1 reference

12 December 2020

Bryostatin 1-tamoxifen combinations show synergistic effects on the inhibition of growth of P388 cells in vitro.

1 reference

12 December 2020

Sensitization of human cervical carcinoma cells to cis-diamminedichloroplatinum(II) by bryostatin 1

1 reference

12 December 2020

A phase I trial of bryostatin 1 in patients with advanced malignancy using a 24 hour intravenous infusion.

1 reference

12 December 2020

Phase Ib trial of bryostatin 1 in patients with refractory malignancies

1 reference

12 December 2020

Preclinical pharmacology of the natural product anticancer agent bryostatin 1, an activator of protein kinase C.

1 reference

12 December 2020

1 reference

12 December 2020

Results of single-agent and combination chemotherapy for advanced soft tissue sarcomas. Implications for decision making in the clinic.

1 reference

12 December 2020

Successful treatment of human Waldenström's macroglobulinemia with combination biological and chemotherapy agents

1 reference

12 December 2020